EV/EBITDA
-5.03
+0.17+3.27%
25 min ago
Summary
- As of March 12, 2025, SYRE EV/EBITDA is -5.03, with a rise of +0.17 (+3.27%) during the most recent trading day.
- Over the past year, SYRE EV/EBITDA has increased by +5.65 (+52.90%).
- SYRE EV/EBITDA is now -288.39% below its all-time high of 2.67.
Performance
SYRE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SYRE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.3% | -3.3% | -3.1% |
| 1 m1 month | +20.0% | -20.1% | -18.9% |
| 3 m3 months | +28.9% | -24.0% | -22.2% |
| 6 m6 months | +38.0% | -25.3% | -33.6% |
| ytdytd | +17.7% | -17.7% | -16.5% |
| 1 y1 year | +52.9% | -23.1% | -56.0% |
| 5 y5 years | -235.3% | +757.6% | -83.1% |
SYRE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.9% | -6.30 | +20.2% | |
| 3 m | 3-month | -4.75 | -5.9% | -7.60 | +33.8% |
| 6 m | 6-month | -4.75 | -5.9% | -10.47 | +52.0% |
| 1 y | 1-year | -2.74 | -83.6% | -11.80 | +57.4% |
| 3 y | 3-year | 2.67 | -288.4% | -11.80 | +57.4% |
| 5 y | 5-year | 2.67 | -288.4% | -11.80 | +57.4% |
| alltime | all time | 2.67 | -288.4% | -11.80 | +57.4% |
Spyre Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.03(-17.7%) |
| 2024 | -6.11(+32.8%) |
| 2023 | -4.60(<-9900.0%) |
| 2022 | 0.01(-100.3%) |
| 2021 | -3.50(-3.8%) |
| Date | Value |
|---|---|
| 2020 | -3.64(+40.0%) |
| 2019 | -2.60(-25.9%) |
| 2018 | -3.51(+24.5%) |
| 2017 | -2.82(+475.5%) |
| 2016 | -0.49 |
FAQ
- What is Spyre Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Spyre Therapeutics?
- What is SYRE EV/EBITDA year-to-date change?
- What is Spyre Therapeutics EV/EBITDA year-on-year change?
What is Spyre Therapeutics EV/EBITDA?
The current EV/EBITDA of SYRE is -5.03
What is the all time high EV/EBITDA for Spyre Therapeutics?
Spyre Therapeutics all-time high EV/EBITDA is 2.67
What is SYRE EV/EBITDA year-to-date change?
Spyre Therapeutics EV/EBITDA has changed by +1.08 (+17.68%) since the beginning of the year
What is Spyre Therapeutics EV/EBITDA year-on-year change?
Over the past year, SYRE EV/EBITDA has changed by +5.65 (+52.90%)